These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Apomorphine in malignant syndrome due to levodopa withdrawal. Bonuccelli U, Piccini P, Corsini GU, Muratorio A. Ital J Neurol Sci; 1992 Mar; 13(2):169-70. PubMed ID: 1592579 [Abstract] [Full Text] [Related]
3. Neuroleptic malignant syndrome without neuroleptics. Ong KC, Chew EL, Ong YY. Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199 [Abstract] [Full Text] [Related]
5. Successful treatment of levodopa-induced myoclonus and levodopa withdrawal-induced neuroleptic malignant syndrome. A case report. Hirschorn KA, Greenberg HS. Clin Neuropharmacol; 1988 Jun; 11(3):278-81. PubMed ID: 3401861 [No Abstract] [Full Text] [Related]
6. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy. Keyser DL, Rodnitzky RL. Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810 [Abstract] [Full Text] [Related]
7. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal. Friedman JH, Feinberg SS, Feldman RG. JAMA; 1985 Nov 15; 254(19):2792-5. PubMed ID: 4057489 [Abstract] [Full Text] [Related]
8. Neuroleptic malignant syndrome without withdrawal of levodopa. Singla R, Singla A, Kumar S, Kar P. Natl Med J India; 2009 Nov 15; 22(3):162. PubMed ID: 19764697 [No Abstract] [Full Text] [Related]
9. Levodopa withdrawal syndrome identical to neuroleptic malignant syndrome. Gibb WR, Griffith DN. Postgrad Med J; 1986 Jan 15; 62(723):59-60. PubMed ID: 3797365 [Abstract] [Full Text] [Related]
12. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay. Bonnici A, Ruiner CE, St-Laurent L, Hornstein D. Ann Pharmacother; 2010 Sep 15; 44(9):1504-7. PubMed ID: 20628041 [Abstract] [Full Text] [Related]
13. Neuroleptic malignant syndrome-like, or--dopaminergic malignant syndrome--due to levodopa therapy withdrawal. Clinical features in 11 patients. Serrano-Dueñas M. Parkinsonism Relat Disord; 2003 Jan 15; 9(3):175-8. PubMed ID: 12573874 [Abstract] [Full Text] [Related]
16. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study. Ward C. J Neurosci Nurs; 2005 Jun 15; 37(3):160-2. PubMed ID: 16001822 [Abstract] [Full Text] [Related]
17. Neuroleptic malignant syndrome. When levodopa withdrawal is the cause. Rainer C, Scheinost NA, Lefeber EJ. Postgrad Med; 1991 Apr 15; 89(5):175-8, 180. PubMed ID: 2008397 [Abstract] [Full Text] [Related]
18. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease]. Yamawaki Y, Ogawa N. Rinsho Shinkeigaku; 1991 Jan 15; 31(1):62-7. PubMed ID: 2044308 [Abstract] [Full Text] [Related]